Pneumococcal Infections Drug Pipeline Analysis Report 2024

Pneumococcal Infections Market Outlook Pneumococcal infections continue to be widespread, especially among high-risk groups like young children and the elderly. The rate of invasive pneumococcal infections is particularly high in children under 2 and adults over the age of 65. This substantial health burden is prompting pharmaceutical companies

read more